Leben Laboratories Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Leben Laboratories Private Limited Pharmaceutical Export Portfolio Dataset — 7 Products, $6.3M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Leben Laboratories Private Limited — Pharmaceutical Exporter Profile (2026) | 7 Products, $6.3M Trade | TransData Nexus

Leben Laboratories Private Limited

Indian Pharmaceutical Exporter · Antimalarial & Antiparasitic Specialist · $6.3M Total Trade · DGFT Verified

Leben Laboratories Private Limited is an Indian pharmaceutical exporter with a total trade value of $6.3M across 7 products in 7 therapeutic categories. Based on 399 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Albendazole ($1.7M), Griseofulvin ($1.5M), Trimethoprim ($1.2M).

Leben Laboratories Private Limited — Export Portfolio & Destination Treemap

Leben Laboratories Private Limited pharmaceutical export portfolio — 7 products across 7 therapeutic categories. Source: Indian Customs (DGFT).

Who is Leben Laboratories Private Limited? — Company Overview & Market Position

Leben Laboratories Private Limited, established on August 2, 1988, is a privately held pharmaceutical company headquartered in Mumbai, Maharashtra, India. The company operates under the Corporate Identification Number (CIN) U24230MH1988PTC048316 and is registered with the Registrar of Companies, Mumbai. As of the latest available data, Leben Laboratories has an authorized capital of ₹2.00 crore and a paid-up capital of ₹36.00 lakh.

The company specializes in the development, manufacturing, distribution, and marketing of a diverse range of pharmaceutical products, including antibiotics, anti-allergic, anti-inflammatory, analgesic, anti-hypertensive, anti-pyretic, antacids, anti-infective, anti-malarial, antiseptic, disinfectants, respiratory, haematinic, and multivitamins. Leben Laboratories has a significant presence in both domestic and international markets, exporting to over 18 countries worldwide.

What Does Leben Laboratories Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Albendazole$1.7M 2

Product Portfolio — Top 7 by Export Value

Leben Laboratories Private Limited exports 7 pharmaceutical products across 7 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Albendazole	Antimalarial & Antiparasitic	$1.7M	53	2.3%	10
2	Griseofulvin	Advanced Antifungals	$1.5M	74	4.0%	3
3	Trimethoprim	Advanced Antibiotics	$1.2M	29	4.5%	2
4	Miconazole	Antifungals	$1.1M	102	5.4%	3
5	Chlorpheniramine	Antihistamines & Allergy	$451.6K	81	1.0%	14
6	Indomethacin	Analgesics & Antipyretics	$419.7K	57	4.5%	5
7	Ibuprofen Paracetamol	Combination Drugs	$15.1K	3	0.8%	7

Leben Laboratories Private Limited exports 7 pharmaceutical products across 7 therapeutic categories with a total export value of $6.3M. The top category is Antimalarial & Antiparasitic (26.4% of portfolio), followed by Advanced Antifungals (23.4%), indicating a concentrated portfolio with the top 5 products accounting for 93.0% of total export value.

Leben Laboratories Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Leben Laboratories operates two state-of-the-art manufacturing plants located in Akola, Maharashtra. The first facility, situated at Plot No. L-4, Phase-III, MIDC, Akola-444104, spans an area of 45,529 square meters and is WHO-GMP certified. The second facility, located at Plot No. L-15, Phase-III, MIDC, Akola-444104, is also WHO-GMP certified. A third manufacturing facility is currently under construction, which will further enhance the company's production capabilities.

3Key Leadership

The leadership team at Leben Laboratories is headed by Shri Bharat N. Shah, who serves as the Chairman and Managing Director. He holds a Master of Pharmacy and has been instrumental in the company's growth since its inception. Shri Parth B. Shah, the Technical Director, holds a Bachelor of Pharmacy and an MBA, contributing significantly to the company's technical and operational advancements.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Leben Laboratories Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Leben Laboratories has established a strong presence in regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company's manufacturing facilities are audited and approved by the U.S. Food and Drug Administration (FDA), the World Health Organization's Good Manufacturing Practice (WHO-GMP), and ISO standards. These certifications facilitate the company's access to these markets, ensuring compliance with stringent regulatory requirements.

2Emerging Markets

Leben Laboratories has expanded its reach into emerging markets across Africa, Latin America, and Southeast Asia. The company's products are approved by various national regulatory authorities, including the Afghanistan Food and Drug Authority (AFDA), Nepal's Department of Drug Administration (DDA), Ethiopia's Food and Drug Authority (EFDA), Uganda's National Drug Authority (NDA), Sri Lanka's National Medicines Regulatory Authority (NMRA), Malawi's Pharmacy, Medicines and Regulatory Authority (PMRA), Kenya's Pharmacy and Poisons Board (PPB), Yemen's Supreme Board of Drugs and Medical Appliances (SBDMA), and Zambia's Medicines Regulatory Authority (ZAMRA). These approvals enable Leben Laboratories to distribute its products in these regions, contributing to the company's global footprint.

Geographic Strategy

Leben Laboratories Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Leben Laboratories' manufacturing facilities are registered with the U.S. Food and Drug Administration (FDA), ensuring compliance with U.S. regulatory standards. The company's products are approved for export to the United States, reflecting adherence to FDA guidelines. While specific details regarding Abbreviated New Drug Applications (ANDAs), Drug Master Files (DMFs), and inspection history are not publicly disclosed, the FDA's approval of the company's facilities and products indicates a positive regulatory standing.

2WHO & EU GMP

Leben Laboratories' manufacturing facilities hold certifications from the World Health Organization's Good Manufacturing Practice (WHO-GMP) and the European Union's Good Manufacturing Practice (EU GMP). These certifications attest to the company's commitment to maintaining high-quality manufacturing standards, facilitating access to international markets that require such compliance.

3CDSCO & Indian Regulatory

Leben Laboratories Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Leben Laboratories operates in a competitive pharmaceutical market, facing competition from both domestic and international companies. While specific market share data for overlapping categories is not publicly available, the company's diverse product portfolio and international certifications position it favorably in the market. The company's focus on quality manufacturing and regulatory compliance enhances its competitiveness in the global pharmaceutical industry.

2Key Differentiators

Leben Laboratories' key differentiators include its state-of-the-art manufacturing facilities, which are WHO-GMP and EU GMP certified, and its diverse product portfolio spanning multiple therapeutic categories. The company's strategic geographic diversification and adherence to international quality standards further distinguish it in the pharmaceutical industry.

3Strategic Position

Leben Laboratories' current strategic direction focuses on expanding its presence in both regulated and emerging markets, leveraging its manufacturing capabilities and regulatory approvals. The company's future outlook includes further diversification of its product portfolio and geographic reach, aiming for sustainable growth and enhanced global competitiveness.

Buyer Due Diligence Brief — Evaluating Leben Laboratories Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Leben Laboratories has a commendable track record in pharmaceutical manufacturing, with over three decades of experience in developing, manufacturing, and exporting pharmaceutical products. The company's export volume and consistency are supported by its international certifications and regulatory approvals, indicating reliability and adherence to quality standards.

2Certifications to Verify

Importers should verify the following certifications when considering products from Leben Laboratories:

FDA Registration: Confirm the company's manufacturing facilities are registered with the U.S. Food and Drug Administration.

WHO-GMP Certification: Ensure the manufacturing facilities hold certification from the World Health Organization's Good Manufacturing Practice.

EU GMP Certification: Verify the facilities are certified under the European Union's Good Manufacturing Practice.

Frequently Asked Questions — Leben Laboratories Private Limited

How many pharmaceutical products does Leben Laboratories Private Limited export from India?

Leben Laboratories Private Limited exports 7 pharmaceutical products across 7 therapeutic categories. The top exports are Albendazole ($1.7M), Griseofulvin ($1.5M), Trimethoprim ($1.2M), Miconazole ($1.1M), Chlorpheniramine ($451.6K). Total export value is $6.3M.

What is Leben Laboratories Private Limited's total pharmaceutical export value?

Leben Laboratories Private Limited's total pharmaceutical export value is $6.3M, based on 399 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Leben Laboratories Private Limited cover?

Leben Laboratories Private Limited exports across 7 therapeutic categories. The largest are Antimalarial & Antiparasitic (26.4%, 1 products), Advanced Antifungals (23.4%, 1 products), Advanced Antibiotics (18.9%, 1 products).

Get Full Leben Laboratories Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.